tiprankstipranks
Aeon Biopharma price target lowered to $6 from $18 at H.C. Wainwright
PremiumThe FlyAeon Biopharma price target lowered to $6 from $18 at H.C. Wainwright
2M ago
Aeon Biopharma provides update on development pipeline
PremiumThe Fly
Aeon Biopharma provides update on development pipeline
2M ago
Aeon’s results from Phase 2 trial of ABP-450 didn’t meet primary endpoint
PremiumThe Fly
Aeon’s results from Phase 2 trial of ABP-450 didn’t meet primary endpoint
3M ago
CORRECTION — AEON Biopharma Announces Redemption of Public Warrants
PremiumPress ReleasesCORRECTION — AEON Biopharma Announces Redemption of Public Warrants
4M ago
AEON Biopharma Announces Redemption of Public Warrants
PremiumPress Releases
AEON Biopharma Announces Redemption of Public Warrants
4M ago
AEON Biopharma Reports Fourth Quarter and Full Year 2023 Financial Results
PremiumPress Releases
AEON Biopharma Reports Fourth Quarter and Full Year 2023 Financial Results
4M ago
Aeon Biopharma presents new data from ABP-450 trial
PremiumThe FlyAeon Biopharma presents new data from ABP-450 trial
6M ago
AEON Biopharma Presents Positive Clinical and Pre-clinical Data for ABP-450 (prabotulinumtoxinA) in Treating Cervical Dystonia and PTSD, Respectively, at a Leading Neurotoxin Conference
PremiumPress Releases
AEON Biopharma Presents Positive Clinical and Pre-clinical Data for ABP-450 (prabotulinumtoxinA) in Treating Cervical Dystonia and PTSD, Respectively, at a Leading Neurotoxin Conference
6M ago
Aeon Biopharma completes enrollment in Phase 2 study of ABP-450
PremiumThe Fly
Aeon Biopharma completes enrollment in Phase 2 study of ABP-450
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100